相关实验视频
Updated: May 24, 2025
07:06
Pentylenetetrazole-Induced Kindling Mouse Model
Published on: June 12, 2018
32.8K
载有瓦尔酸盐和甲胺的固体脂质纳米颗粒对大鼠中素引发的的影响
R Abinaya1, V K Kalaichelvan2, K Gopalasatheeskumar3
1Department of Pharmacology, Adhiparasakthi College of Pharmacy (Affiliated to the Tamil Nadu Dr.M.G.R. Medical University), Melmaruvathur, Kancheepuram, 603319, Tamil Nadu, India. rakshitharavi24@gmail.com.
Naunyn-Schmiedeberg's archives of pharmacology
|March 5, 2025
概括
这项研究开发了一种新的纳米配方,结合了酸和甲福明来治疗. 虽然没有优于单独的酸,但纳米配方增强了生物可用性和降低了毒性,为管理提供了有前途的替代方案.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 纳米技术纳米技术
背景情况:
- 酸是一种主要的治疗方法,但可能导致肝毒性.
- 用于治疗2型糖尿病的甲福明通过AMPK激活显示出潜在的肝保护和抗作用.
- 将这些药物组合到纳米配方中可以提高疗效并减少副作用.
研究的目的:
- 为了研究酸和甲胺封装固体脂质纳米配方的抗活性.
- 为了评估这种纳米配方在小鼠中对乙烯甲醇诱导的的疗效.
- 评估纳米配方对神经递质水平的影响,并将其影响与单独的氨酸相比较.
主要方法:
- 酸和甲胺被封装成固体脂质纳米颗粒,使用溶剂蒸发和超声波.
- 酸 (6%) 被优化为纳米粒子配方的固体脂质.
- 抗活性被评估在乙诱导的性大鼠中,测量了的严重程度,持续时间和神经递质水平 (GABA,血清素,谷氨酸).
主要成果:
- 优化的纳米配方显示,的持续时间和严重程度显著减少.
- 用氨酸和甲胺载荷纳米颗粒治疗增加了GABA和血清素水平,同时降低了谷氨酸水平.
- 纳米配方,在较低的剂量下,显示出与单独的氨酸具有可比的疗效,表明增强的生物可用性和降低的毒性.
结论:
- 瓦尔酸盐和甲胺装载的固体脂质纳米颗粒为治疗提供了一种有前途的方法.
- 该纳米配方增强了生物可用性,并可能减少与氨酸单一治疗相比,剂量相关的毒性.
- 这种方法需要进一步研究,以改善管理策略.
相关概念视频
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
209
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
209
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
306
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
306
01:08Antiepileptic Drugs: Sodium Channel Blockers
340
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
340
01:20Antiepileptic Drugs: Potassium Channel Activators
140
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
140
01:17Antiepileptic Drugs: Calcium Channel Blockers
290
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
290
01:14Antiepileptic Drugs: Glutamate Antagonists
267
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
267